Literature DB >> 32606192

Microsatellite Instability Correlated Inflammatory Markers and their Prognostic Value in the Rectal Cancer Following Neoadjuvant Chemoradiotherapy: A Hypothesis-generating Study.

Joo Ho Lee1,2, Byung-Hee Kang2, Changhoon Song1, Sung-Bum Kang3, Hye Seung Lee4, Keun-Wook Lee5, Eui Kyu Chie6, Jae-Sung Kim7.   

Abstract

BACKGROUND/AIM: This study aimed to analyze the correlation between microsatellite instability (MSI) and inflammatory markers during neoadjuvant CRT in rectal cancer and its influence on prognosis. PATIENTS AND METHODS: A total of 549 patients with locally advanced rectal cancer underwent neoadjuvant CRT. Complete blood counts before CRT, and 4-8 weeks after CRT were used to measure neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR).
RESULTS: MSI was significantly associated with elevated NLR and PLR after CRT as well as with a change in NLR and PLR during CRT. Neither inflammatory markers nor MSI significantly related to survival. However, in patients with MSI, an increase in NLR and PLR before CRT was significantly correlated with poor overall survival and disease-free survival.
CONCLUSION: There is correlation between inflammatory markers and MSI during CRT and it influences prognosis. Therefore, inflammatory markers might have a role in assessing the microenvironment related to MSI and the immunologic response in rectal cancer. Copyright
© 2020, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Rectal cancer; chemoradiotherapy; inflammatory markers; microsatellite instability

Mesh:

Year:  2020        PMID: 32606192      PMCID: PMC7439872          DOI: 10.21873/invivo.12017

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  28 in total

1.  Predicting Pathological Complete Regression with Haematological Markers During Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer.

Authors:  Joo Ho Lee; Changhoon Song; Sung-Bum Kang; Hye Seung Lee; Keun-Wook Lee; Jae-Sung Kim
Journal:  Anticancer Res       Date:  2018-12       Impact factor: 2.480

2.  Microsatellite Instability (MSI) as an Independent Predictor of Pathologic Complete Response (PCR) in Locally Advanced Rectal Cancer: A National Cancer Database (NCDB) Analysis.

Authors:  Shaakir Hasan; Paul Renz; Rodney E Wegner; Gene Finley; Moses Raj; Dulabh Monga; James McCormick; Alexander Kirichenko
Journal:  Ann Surg       Date:  2020-04       Impact factor: 12.969

Review 3.  Acute-phase proteins and other systemic responses to inflammation.

Authors:  C Gabay; I Kushner
Journal:  N Engl J Med       Date:  1999-02-11       Impact factor: 91.245

Review 4.  Radiotherapy and immunotherapy: a beneficial liaison?

Authors:  Ralph R Weichselbaum; Hua Liang; Liufu Deng; Yang-Xin Fu
Journal:  Nat Rev Clin Oncol       Date:  2017-01-17       Impact factor: 66.675

Review 5.  Microsatellite Instability and Survival in Stage II Colorectal Cancer: A Systematic Review and Meta-analysis.

Authors:  Fausto Petrelli; Michele Ghidini; Mary Cabiddu; Ezio Pezzica; Daniela Corti; Luca Turati; Antonio Costanzo; Antonio Varricchio; Antonio Ghidini; Sandro Barni; Gianluca Tomasello
Journal:  Anticancer Res       Date:  2019-12       Impact factor: 2.480

6.  Circulating myeloid-derived suppressor cells are increased and correlate to immune suppression, inflammation and hypoproteinemia in patients with cancer.

Authors:  Shinji Ohki; Masahiko Shibata; Kenji Gonda; Takeshi Machida; Tatsuo Shimura; Izumi Nakamura; Toru Ohtake; Yoshihisa Koyama; Shinichi Suzuki; Hitoshi Ohto; Seiichi Takenoshita
Journal:  Oncol Rep       Date:  2012-05-14       Impact factor: 3.906

7.  Low-level microsatellite instability in most colorectal carcinomas.

Authors:  Päivi Laiho; Virpi Launonen; Päivi Lahermo; Manel Esteller; Mingzhou Guo; James G Herman; Jukka-Pekka Mecklin; Heikki Järvinen; Pertti Sistonen; Kyoung-Mee Kim; Darryl Shibata; Richard S Houlston; Lauri A Aaltonen
Journal:  Cancer Res       Date:  2002-02-15       Impact factor: 12.701

8.  The combination of systemic inflammation-based marker NLR and circulating regulatory T cells predicts the prognosis of resectable pancreatic cancer patients.

Authors:  He Cheng; Guopei Luo; Yu Lu; Kaizhou Jin; Meng Guo; Jin Xu; Jiang Long; Liang Liu; Xianjun Yu; Chen Liu
Journal:  Pancreatology       Date:  2016-09-16       Impact factor: 3.996

9.  The influence of the treatment response on the impact of resection margin status after preoperative chemoradiotherapy in locally advanced rectal cancer.

Authors:  Joo Ho Lee; Eui Kyu Chie; Kyubo Kim; Seung-Yong Jeong; Kyu Joo Park; Jae-Gahb Park; Gyeong Hoon Kang; Sae-Won Han; Do-Youn Oh; Seock-Ah Im; Tae-You Kim; Yung-Jue Bang; Sung W Ha
Journal:  BMC Cancer       Date:  2013-12-05       Impact factor: 4.430

10.  The consensus molecular subtypes of colorectal cancer.

Authors:  Justin Guinney; Rodrigo Dienstmann; Xin Wang; Aurélien de Reyniès; Andreas Schlicker; Charlotte Soneson; Laetitia Marisa; Paul Roepman; Gift Nyamundanda; Paolo Angelino; Brian M Bot; Jeffrey S Morris; Iris M Simon; Sarah Gerster; Evelyn Fessler; Felipe De Sousa E Melo; Edoardo Missiaglia; Hena Ramay; David Barras; Krisztian Homicsko; Dipen Maru; Ganiraju C Manyam; Bradley Broom; Valerie Boige; Beatriz Perez-Villamil; Ted Laderas; Ramon Salazar; Joe W Gray; Douglas Hanahan; Josep Tabernero; Rene Bernards; Stephen H Friend; Pierre Laurent-Puig; Jan Paul Medema; Anguraj Sadanandam; Lodewyk Wessels; Mauro Delorenzi; Scott Kopetz; Louis Vermeulen; Sabine Tejpar
Journal:  Nat Med       Date:  2015-10-12       Impact factor: 53.440

View more
  2 in total

1.  Meta-Analysis on the Neutrophil-Lymphocyte Ratio in Rectal Cancer Treated With Preoperative Chemoradiotherapy: Prognostic Value of Pre- and Post-Chemoradiotherapy Neutrophil-Lymphocyte Ratio.

Authors:  Soo Jin Lee; Kyubo Kim; Hae Jin Park
Journal:  Front Oncol       Date:  2022-02-11       Impact factor: 6.244

2.  Microsatellite instability in rectal cancer: what does it mean? A study of two randomized trials and a systematic review of the literature.

Authors:  Marloes Swets; Cristina Graham Martinez; Shannon van Vliet; Arjan van Tilburg; Hans Gelderblom; Corrie A M Marijnen; Cornelis J H van de Velde; Iris D Nagtegaal
Journal:  Histopathology       Date:  2022-07-14       Impact factor: 7.778

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.